In a PPAR-γ-dependent manner, PGZ decreases the expression level of β-catenin protein, a crucial carcinogenic mediator, and suppresses glioma cells growth and invasion both in vitro and in vivo as in mice xenograft (83). Here, PPARG is linked to central nervous system cancer.